WallStreetZenWallStreetZen

NASDAQ: LENZ
Lenz Therapeutics Inc Stock Ownership - Who owns Lenz Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Lenz Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Versant Venture Capital VI LP10% Owner2025-08-2643,978$38.97
$1.71MSell
Versant Venture Capital VI LP10% Owner2025-08-261,707$39.50
$67.43kSell
Versant Venture Capital VI LP10% Owner2025-08-263,465$39.50
$136.87kSell
Versant Venture Capital VI LP10% Owner2025-08-2621,661$38.97
$844.22kSell
Versant Venture Capital VI LP10% Owner2025-08-252,149$39.92
$85.79kSell
Versant Venture Capital VI LP10% Owner2025-08-251,058$39.92
$42.24kSell
Versant Venture Capital VI LP10% Owner2025-08-2524,760$39.53
$978.66kSell
Versant Venture Capital VI LP10% Owner2025-08-2550,270$39.53
$1.99MSell
Versant Venture Capital VI LP10% Owner2025-08-2220,493$40.03
$820.33kSell
Versant Venture Capital VI LP10% Owner2025-08-222,809$40.59
$114.02kSell

1 of 3

LENZ insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when LENZ insiders and whales buy or sell their stock.

LENZ Shareholders

What type of owners hold Lenz Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Ecor1 Capital LLC29.94%8,538,446$352.94MInsider
Samsara Biocapital LP29.92%8,534,820$352.79MInsider
Ra Capital Management LP14.65%4,178,823$172.73MInstitution
Alpha Wave Global LP12.66%3,612,211$149.31MInstitution
Alpha Wave Ventures GP Ltd12.66%3,612,211$149.31MInsider
Versant Venture Capital VI LP7.42%2,116,359$87.48MInsider
Paradigm Biocapital Advisors LP6.02%1,717,066$70.97MInstitution
Davis Jerel5.99%1,707,719$70.59MInsider
Versant Venture Capital VII LP5.61%1,598,789$66.09MInsider
Blackrock Inc5.02%1,432,461$59.21MInstitution

1 of 3

LENZ vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
LENZ45.52%54.48%Net SellingNet Selling
ETNB90.91%9.09%Net BuyingNet Selling
ELVN49.48%50.52%Net SellingNet Selling
NTLA71.81%28.19%Net BuyingNet Buying
DNTH53.74%46.26%Net BuyingNet Buying
View Top Biotech Stocks

Lenz Therapeutics Stock Ownership FAQ

Who owns Lenz Therapeutics?

Lenz Therapeutics (NASDAQ: LENZ) is owned by 86.69% institutional shareholders, 103.74% Lenz Therapeutics insiders, and 0.00% retail investors. Ecor1 Capital LLC is the largest individual Lenz Therapeutics shareholder, owning 8.54M shares representing 29.94% of the company. Ecor1 Capital LLC's Lenz Therapeutics shares are currently valued at $352.94M.

If you're new to stock investing, here's how to buy Lenz Therapeutics stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.